NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-045-2015-0-CH-12 Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use CH EP 15797815.6 Issued
NIAID E-045-2015-0-DE-07 Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use DE EP 15797815.6 Issued
NCI E-093-2013-2-US-08 Compounds for Inhibiting Drug-Resistant Strains of HIV-1 Integrase US National Stage 14/891,309 9676771 Issued PDF
NIAID E-278-2016-0-PCT-02 Antibodies That Neutralize Ebola Virus And Uses Thereof PCT PCT PCT/IB2015/002342 Expired
NCI E-186-2015-0-PCT-01 Peptide and Peptide Mimetic Binding Antagonists of Polo-Like Kinase 1 Polo Box Domain and Methods of Use PCT PCT PCT/US2015/060629 Expired
NIAID E-045-2015-0-PCT-02 Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use PCT PCT PCT/US2015/060733 Expired
NHLBI E-036-2015-1-PCT-01 NK Cells with an Increased Antibody-Dependent Cellular Toxicity (ADCC) Against Tumors PCT PCT COMB PCT/US2015/060646 Expired
NIDDK E-034-2015-0-PCT-02 Device and System for Manipulating Small Model Organisms PCT PCT PCT/US2015/060575 Expired
NIDDK E-034-2015-0-EP-04 Device and System for Manipulating Small Model Organisms EP National Stage 15805014.6 Abandoned
NIDDK E-034-2015-0-CN-03 Device and System for Manipulating Small Model Organisms CN National Stage 201580073355.6 Abandoned
NCI E-139-2015-0-US-01 Fixatives and Methods of Use US 62/255,030 Abandoned
NCI E-010-2016-0-US-01 Anti-BCMA Polypeptides and Conjugates US 62/255,255 Abandoned
NICHD E-039-2016-1-CA-04 Treatment of Hormonal Disorders of Growth CA National Stage 2965696 Issued
NCI E-226-2014-0-CA-04 Anti-Human Thyroglobulin T Cell Receptors CA National Stage 2967778 Issued
NICHD E-039-2016-1-DE-08 Treatment of Hormonal Disorders of Growth DE EP 15798305.7 Issued
NICHD E-039-2016-1-FR-09 Treatment of Hormonal Disorders of Growth FR EP 15798305.7 Issued
NICHD E-039-2016-1-EP-05 Treatment of Hormonal Disorders of Growth EP National Stage 15798305.7 Issued
NICHD E-039-2016-1-GB-10 Treatment of Hormonal Disorders of Growth GB EP 15798305.7 Issued
NCI E-226-2014-0-AU-03 ANTI-THYROGLOBULIN T CELL RECEPTORS AU National Stage 2015346350 Issued
NCI E-226-2014-0-FR-10 Anti-Human Thyroglobulin T Cell Receptors FR EP 15801054.6 Issued
NCI E-226-2014-0-DE-11 Anti-Human Thyroglobulin T Cell Receptors DE EP 15801054.6 Issued
NCI E-226-2014-0-GB-12 Anti-Human Thyroglobulin T Cell Receptors GB EP 15801054.6 Issued
NCI E-226-2014-0-EP-05 Anti-Human Thyroglobulin T Cell Receptors EP National Stage 15801054.6 Issued
NCI E-226-2014-0-JP-06 Anti-Human Thyroglobulin T Cell Receptors JP National Stage 2017-525625 Issued
NICHD E-039-2016-1-PCT-01 Treatment of Hormonal Disorders of Growth PCT PCT COMB PCT/US2015/060442 Expired
NCI E-226-2014-0-PCT-02 HUMAN ANTI-THYROGLOBULIN T CELL RECEPTORS PCT PCT PCT/US2015/060282 Expired
NCI E-054-2013-2-HK-11 IL-15R ALPHA FORMS, CELLS EXPRESSING IL-15R ALPHA FORMS, AND THERAPEUTIC USES OF IL-15R ALPHA AND IL-15/IL-15R ALPHA COMPLEXES HK National Stage 15112238.0 Abandoned
NCI E-033-2013-1-CN-02 Stabilized Single Human CD4 Domains And Fusion Proteins CN National Stage 201480026873.8 Issued
CC E-149-2014-0-IE-07 Topical Sodium Nitrite Formulation IE EP 15798623.3 Issued
CC E-149-2014-0-DE-05 Topical Sodium Nitrite Formulation DE EP 15798623.3 Issued
CC E-149-2014-0-FR-06 Topical Sodium Nitrite Formulation FR EP 15798623.3 Issued
CC E-149-2014-0-EP-03 Topical Sodium Nitrite Formulation EP National Stage 15798623.3 Issued
CC E-149-2014-0-GB-08 Topical Sodium Nitrite Formulation GB EP 15798623.3 Issued
CC E-149-2014-0-PCT-02 Topical Sodium Nitrite Formulation PCT PCT PCT/US2015/060015 Expired
NIDCR E-033-2004-0-US-13 Multipotent Postnatal Stem Cells From Human Periodontal Ligament and Uses Thereof US CON 14/936,529 10046012 Expired PDF
NIAID E-152-2015-2-PCT-01 Probiotic Therapeutic Applications PCT PCT COMB PCT/US2015/059662 Expired
NCI E-285-2016-0-US-01 Glypican 2 As A Cancer Marker And Therapeutic Target US 62/253,000 Abandoned
NIAID E-152-2015-2-CA-02 Probiotic Therapeutic Applications CA National Stage 2967039 Abandoned
NCI E-025-2010-0-CA-04 Diazeniumdiolated Compounds, Pharmaceutical Compositions, And Methods of Treating Cancer CA National Stage 2780633 Issued
NIAID E-136-2013-0-US-05 Single-Domain VHH Antibodies Directed to NoroVirus Gi.1 and Gii.4 and Their Use US National Stage 14/889,774 10000556 Abandoned PDF
NCI E-261-2016-0-PCT-02 Compositions And Methods Of Diazeniumdiolate-based Prodrugs For Treating Cancer PCT PCT PCT/US2015/059428 Expired
NICHD E-209-2021-0-US-01 Kits And Methods To Distinguish False Labor And True Labor US 62/251,517 Abandoned
NICHD E-210-2021-0-US-01 Kits And Methods For Predictions And Treatment Of Preeclampsia US 62/251,589 Abandoned
NHLBI E-034-2016-0-US-01 TSLP Induces Neutrophil Mediated Killing Of Methicillin-resistant Staphylococcus Aureus US 62/251,558 Abandoned
NHLBI E-141-2009-0-US-03 APPARATUS AND METHOD FOR MAGNETIC RESONANCE IMAGING WITH HIGH SPATIAL TEMPORAL RESOLUTIONS US National Stage 14/889,135 10371779 Issued PDF
NHLBI E-166-2014-0-PCT-02 T Cells and Dendritic Cells for Polyomavirus Therapy PCT PCT PCT/US2015/059021 Expired
NIAID E-067-2016-0-US-01 A Novel Method Of Vaccination With An Attenuated RSV Vaccine Formulation US 62/251,030 Abandoned
NIDDK E-038-2016-0-US-01 EXPRESSION OF IGF2BP1 FOR TREATMENT US 62/250,815 Abandoned
NCI E-055-2017-0-US-01 Combing D2C7 Immunotoxin With Check Points Inhibitors US 62/250,749 Abandoned
NIAMS E-073-2011-2-US-01 Antibodies the Bind to TL1A and Methods of Treating Inflammatory or Autoimmune Disease Comprising Administering Such Antibodies US CIP 14/931,149 9896511 Issued PDF